Details for New Drug Application (NDA): 211881
✉ Email this page to a colleague
NDA 211881 describes FOSFOMYCIN TROMETHAMINE, which is a drug marketed by Alkem Labs Ltd, Amneal, Cipla, and Xiromed, and is included in four NDAs. It is available from five suppliers. Additional details are available on the FOSFOMYCIN TROMETHAMINE profile page.
The generic ingredient in FOSFOMYCIN TROMETHAMINE is fosfomycin tromethamine. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fosfomycin tromethamine profile page.
The generic ingredient in FOSFOMYCIN TROMETHAMINE is fosfomycin tromethamine. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fosfomycin tromethamine profile page.
Summary for 211881
| Tradename: | FOSFOMYCIN TROMETHAMINE |
| Applicant: | Cipla |
| Ingredient: | fosfomycin tromethamine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 211881
Suppliers and Packaging for NDA: 211881
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FOSFOMYCIN TROMETHAMINE | fosfomycin tromethamine | FOR SOLUTION;ORAL | 211881 | ANDA | Cipla USA Inc. | 69097-579 | 69097-579-67 | 1 DOSE PACK in 1 CARTON (69097-579-67) / 1 GRANULE, FOR SOLUTION in 1 DOSE PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 3GM BASE/PACKET | ||||
| Approval Date: | Jan 26, 2022 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
